BioRegenx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.07	0.06	0.13	0	0.88
Cash & Short-Term Investments	0.07	0.06	0.13	0	0.88
Cash Growth	18.80%	-53.43%	18450.59%	-99.92%	48.76%
Receivables	0.04	0.01	0.1	-	0
Inventory	0.11	0.11	0.22	-	0.65
Prepaid Expenses	0.01	0.01	0.06	-	0.24
Other Current Assets	0.03	0.12	0.14	-	0.11
Total Current Assets	0.25	0.31	0.65	0	1.89
Property, Plant & Equipment	0.16	0.2	0.01	-	0.02
Long-Term Investments	-	-	-	0.02	-
Other Intangible Assets	-	-	0.05	0.04	-
Other Long-Term Assets	-	-	0.15	-	0.01
Total Assets	0.41	0.51	0.87	0.06	1.92
Accounts Payable	0.97	0.65	0.46	0.02	0.61
Accrued Expenses	1	0.88	0.64	-	1
Short-Term Debt	1.03	1.03	0.96	-	1.32
Current Portion of Long-Term Debt	1	0.88	0.38	0.05	-
Current Unearned Revenue	0.06	0.2	0.35	-	0.07
Total Current Liabilities	4.07	3.63	2.79	0.06	2.99
Long-Term Debt	0.18	0.25	0.15	0.2	2.19
Other Long-Term Liabilities	0.7	-	-	-	-
Total Liabilities	4.95	3.89	2.94	0.26	5.18
Common Stock	0.97	1.23	0.77	0.27	0
Additional Paid-In Capital	31.61	30.97	9.68	2.44	2.7
Retained Earnings	-37.12	-35.57	-12.52	-2.92	-5.96
Comprehensive Income & Other	-	0	-0	-	-
Total Common Equity	-4.54	-3.38	-2.07	-0.21	-3.26
Shareholders' Equity	-4.54	-3.38	-2.07	-0.2	-3.26
Total Liabilities & Equity	0.41	0.51	0.87	0.06	1.92
Total Debt	2.21	2.16	1.49	0.24	3.51
Net Cash (Debt)	-2.15	-2.11	-1.36	-0.24	-2.62
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.07
Filing Date Shares Outstanding	969.02	956.99	956.63	38.88	36.17
Total Common Shares Outstanding	969.02	956.99	956.63	38.58	36.17
Working Capital	-3.82	-3.33	-2.13	-0.06	-1.11
Book Value Per Share	-0.00	-0.00	-0.00	-0.01	-0.09
Tangible Book Value	-4.54	-3.38	-2.12	-0.25	-3.26
Tangible Book Value Per Share	-0.00	-0.00	-0.00	-0.01	-0.09

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.